U.S. market Closed. Opens in 11 hours 21 minutes

MYMD | MyMD Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
RevenueN/AN/AN/AN/A1.58M1.67M3.93M2.96M2.12M4.43M3.58M1.52M1.79M3.05M1.84M6.08M5.52M1.02M4.61M
Cost of RevenueN/AN/AN/A29.45K74.06K1.54M1.42M1.08M950.79K1.18M1.91M975.95K894.56K1.29M1.10M1.37M2.01M2.46M2.94M
Gross ProfitN/AN/AN/A-29.45K1.50M127.28K2.51M1.88M1.16M3.25M1.66M546.41K890.51K1.77M743.46K4.71M3.51M-1.44M1.67M
Operating Expenses17.12M15.28M28.20M8.30M3.32M8.68M7.56M6.51M8.22M6.46M3.47M3.17M4.74M2.90M5.41M2.69M5.25M7.39M3.88M
Selling, General & Admin8.49M6.22M21.46M5.81M3.32M7.45M6.13M5.15M6.57M5.28M2.21M2.13M3.99M1.89M4.31M151.65K283.08KN/AN/A
Research & Development7.87M9.07M6.75M2.47M3.63M1.06M1.26M1.19M1.41M916.31K1.01M717.15K698.43K674.68K662.08K431.63K126.48K787.28K789.62K
Other Operating Expenses-762.83KN/AN/A18.33K40.01K171.11K171.11K171.11K236.71K258.57K258.57K320.13K59.16K337.32K434.81K2.11M4.84M6.60M3.09M
Operating Income-17.12M-15.28M-28.81M-9.49M-3.40M-8.56M-5.05M-4.63M-7.05M-3.20M-1.81M-2.62M-3.85M-1.13M-4.67M2.02M-1.74M-8.83M-2.21M
Other Expenses / Income13.12M85.43K-1.08M141.0015.80K-2.29M-752.52K1.32M-2.53M76.95K283.94K6.86K-29.34K-70.70K37.55K-3.25M-624.39K-1.25M-2.30M
Before Tax Income-4.00M-15.20M-29.89M-9.49M-3.38M-10.85M-5.81M-3.30M-9.58M-3.13M-1.53M-2.61M-3.88M-1.20M-4.63M-1.24M-2.37M-10.08M-4.51M
Income Tax Expenses4.22M-85.43K-8.91K1.19M-83.65K-2.29MN/AN/A-269.34KN/AN/A-163.37K-297.89K-283.41KN/A-699.94K-640.46K-488.86KN/A
Net Income-4.00M-15.11M-29.88M-10.68M-3.89M-10.85M-5.81M-3.30M-9.31M-3.13M-1.53M-2.45M-3.58M-919.88K-4.63M-535.16K-1.72M-9.59M-4.51M
Interest ExpensesN/A-85.43K608.46K1.19MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.28M624.39K1.25M650.27K
Basic Shares Outstanding1.54M1.29M1.17M117.54K10.21K457.25K49.45K28.28K26.77K24.72K8.32K5.95K5.45K3.82K3.79K3.10K2.08K1.90K1.67K
Diluted Shares Outstanding1.54M1.29M1.17M117.54K10.21K457.25K49.45K28.28K26.77K24.72K8.32K5.95K5.45K3.82K3.79K3.10K2.08K1.90K1.67K
EBITDA-17.12M-15.20M-28.19M-8.28M-3.32M-10.61M-5.56M-3.02M-9.28M-2.78M-1.17M-2.07M-3.36M-719.27K-3.71M592.56K-1.74M-8.83M-3.86M
EBITDA Margin0.00%0.00%0.00%0.00%-210.71%-637.29%-141.38%-101.91%-438.82%-62.74%-32.77%-136.27%-188.05%-23.56%-201.05%9.75%-31.54%-864.81%-83.66%
EBIT218.26K-15.28M-29.28M-8.30M-3.97M-13.14M-5.81M-3.30M-9.58M-3.13M-1.53M-2.61M-3.88M-1.20M-4.63M46.66K-1.74M-8.83M-3.86M
EBIT Margin0.00%0.00%0.00%0.00%-251.86%-789.08%-147.74%-111.57%-453.00%-70.64%-42.67%-171.60%-217.48%-39.41%-250.96%0.77%-31.54%-864.81%-83.66%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙